Senti Biosciences
SNTI
SNTI
24 hedge funds and large institutions have $14.3M invested in Senti Biosciences in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$427K | |
| 2 | +$92.1K | |
| 3 | +$35.1K | |
| 4 |
Citigroup
New York
|
+$22.5K |
| 5 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$20.5K |
Top Sellers
| 1 | -$134K | |
| 2 | -$37.9K | |
| 3 | -$33K | |
| 4 |
Millennium Management
New York
|
-$32K |
| 5 |
Renaissance Technologies
New York
|
-$25K |